FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387013003> ?p ?o ?g. }

• W4387013003 abstract "Abstract Background Triple therapy is recommended for patients with chronic obstructive pulmonary disease (COPD) who remain symptomatic despite dual therapy. The optimal timing of triple therapy following an exacerbation of COPD is unknown. The outcomes of prompt (≤ 30 days) vs. delayed (31–180 days) initiation of single-inhaler triple therapy with fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) following an exacerbation of COPD were examined. Methods This was a retrospective cohort study of linked English primary (Clinical Practice Research Datalink) and secondary (Hospital Episode Statistics) care data. Patients aged ≥ 35 years with COPD were indexed on the first and/or earliest date of exacerbation between November 15, 2017 and March 31, 2019 with subsequent FF/UMEC/VI initiation within 180 days. Patients were required to be continuously registered with a general practitioner for ≥ 12 months prior to and following index. Subsequent exacerbations, direct medical costs, and hospital readmissions were compared between prompt and delayed initiators. Inverse probability of treatment weighting was used to adjust for measured confounders between cohorts. Results Overall, 1599 patients were included (prompt: 393, delayed: 1206). After weighting, prompt initiators had numerically lower moderate/severe exacerbations compared with delayed initiators (rate ratio: 0.87, 95% confidence interval [CI]: 0.76–1.01, p = 0.0587). Both all-cause and COPD-related 30-day hospital readmissions were significantly lower among patients with prompt initiation compared with delayed initiators (all-cause: 23.6% vs. 34.6%, odds ratio [95% CI]: 0.58 [0.36–0.95], p = 0.0293; COPD-related: 20.3% vs. 30.6%, odds ratio [95% CI]: 0.58 [0.35–0.96], p = 0.0347). Prompt initiators also had numerically lower all-cause total costs and significantly lower COPD-related costs per-person-per year compared with delayed initiators (COPD-related: £742 vs. £801, p = 0.0016). Conclusion Prompt initiation of FF/UMEC/VI following a moderate/severe exacerbation was associated with fewer subsequent exacerbations, fewer hospital readmissions, and lower COPD-related medical costs compared with delayed initiation." @default.
• W4387013003 created "2023-09-26" @default.
• W4387013003 creator A5001030412 @default.
• W4387013003 creator A5014641457 @default.
• W4387013003 creator A5020186225 @default.
• W4387013003 creator A5031900147 @default.
• W4387013003 creator A5038228413 @default.
• W4387013003 creator A5042278243 @default.
• W4387013003 creator A5046338978 @default.
• W4387013003 creator A5046479681 @default.
• W4387013003 creator A5050171498 @default.
• W4387013003 creator A5064758166 @default.
• W4387013003 creator A5067651492 @default.
• W4387013003 date "2023-09-25" @default.
• W4387013003 modified "2023-10-17" @default.
• W4387013003 title "Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study" @default.
• W4387013003 cites W2295597785 @default.
• W4387013003 cites W2554373806 @default.
• W4387013003 cites W2802221596 @default.
• W4387013003 cites W2898474985 @default.
• W4387013003 cites W2912675200 @default.
• W4387013003 cites W2991383511 @default.
• W4387013003 cites W3041372961 @default.
• W4387013003 cites W3092675167 @default.
• W4387013003 cites W3112009581 @default.
• W4387013003 cites W3112169679 @default.
• W4387013003 cites W3149026346 @default.
• W4387013003 cites W3162059233 @default.
• W4387013003 cites W3203380990 @default.
• W4387013003 cites W4214846659 @default.
• W4387013003 cites W4297015842 @default.
• W4387013003 cites W4307377253 @default.
• W4387013003 doi "https://doi.org/10.1186/s12931-023-02523-1" @default.
• W4387013003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37749551" @default.
• W4387013003 hasPublicationYear "2023" @default.
• W4387013003 type Work @default.
• W4387013003 citedByCount "0" @default.
• W4387013003 crossrefType "journal-article" @default.
• W4387013003 hasAuthorship W4387013003A5001030412 @default.
• W4387013003 hasAuthorship W4387013003A5014641457 @default.
• W4387013003 hasAuthorship W4387013003A5020186225 @default.
• W4387013003 hasAuthorship W4387013003A5031900147 @default.
• W4387013003 hasAuthorship W4387013003A5038228413 @default.
• W4387013003 hasAuthorship W4387013003A5042278243 @default.
• W4387013003 hasAuthorship W4387013003A5046338978 @default.
• W4387013003 hasAuthorship W4387013003A5046479681 @default.
• W4387013003 hasAuthorship W4387013003A5050171498 @default.
• W4387013003 hasAuthorship W4387013003A5064758166 @default.
• W4387013003 hasAuthorship W4387013003A5067651492 @default.
• W4387013003 hasBestOaLocation W43870130031 @default.
• W4387013003 hasConcept C126322002 @default.
• W4387013003 hasConcept C156957248 @default.
• W4387013003 hasConcept C167135981 @default.
• W4387013003 hasConcept C167704817 @default.
• W4387013003 hasConcept C187212893 @default.
• W4387013003 hasConcept C2776042228 @default.
• W4387013003 hasConcept C2776780178 @default.
• W4387013003 hasConcept C2776804153 @default.
• W4387013003 hasConcept C2777014857 @default.
• W4387013003 hasConcept C2778884479 @default.
• W4387013003 hasConcept C2779028295 @default.
• W4387013003 hasConcept C2780261241 @default.
• W4387013003 hasConcept C2781018748 @default.
• W4387013003 hasConcept C44249647 @default.
• W4387013003 hasConcept C71924100 @default.
• W4387013003 hasConcept C72563966 @default.
• W4387013003 hasConceptScore W4387013003C126322002 @default.
• W4387013003 hasConceptScore W4387013003C156957248 @default.
• W4387013003 hasConceptScore W4387013003C167135981 @default.
• W4387013003 hasConceptScore W4387013003C167704817 @default.
• W4387013003 hasConceptScore W4387013003C187212893 @default.
• W4387013003 hasConceptScore W4387013003C2776042228 @default.
• W4387013003 hasConceptScore W4387013003C2776780178 @default.
• W4387013003 hasConceptScore W4387013003C2776804153 @default.
• W4387013003 hasConceptScore W4387013003C2777014857 @default.
• W4387013003 hasConceptScore W4387013003C2778884479 @default.
• W4387013003 hasConceptScore W4387013003C2779028295 @default.
• W4387013003 hasConceptScore W4387013003C2780261241 @default.
• W4387013003 hasConceptScore W4387013003C2781018748 @default.
• W4387013003 hasConceptScore W4387013003C44249647 @default.
• W4387013003 hasConceptScore W4387013003C71924100 @default.
• W4387013003 hasConceptScore W4387013003C72563966 @default.
• W4387013003 hasIssue "1" @default.
• W4387013003 hasLocation W43870130031 @default.
• W4387013003 hasLocation W43870130032 @default.
• W4387013003 hasOpenAccess W4387013003 @default.
• W4387013003 hasPrimaryLocation W43870130031 @default.
• W4387013003 hasRelatedWork W1957064019 @default.
• W4387013003 hasRelatedWork W1978298330 @default.
• W4387013003 hasRelatedWork W2057872475 @default.
• W4387013003 hasRelatedWork W2554469774 @default.
• W4387013003 hasRelatedWork W2561355144 @default.
• W4387013003 hasRelatedWork W2796112680 @default.
• W4387013003 hasRelatedWork W2802779683 @default.
• W4387013003 hasRelatedWork W2935315698 @default.
• W4387013003 hasRelatedWork W4237479062 @default.
• W4387013003 hasRelatedWork W4252463179 @default.
• W4387013003 hasVolume "24" @default.
• W4387013003 isParatext "false" @default.
• W4387013003 isRetracted "false" @default.

• next